Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PFIZER   TEVA PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-22
TEVA PHARMA
Dec-13
PFIZER/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs6,1653,325-   
Low Rs4,1632,888-   
Sales per share (Unadj.) Rs570.71,908.0-  
Earnings per share (Unadj.) Rs133.9119.2-  
Cash flow per share (Unadj.) Rs159.0273.4-  
Dividends per share (Unadj.) Rs35.00104.34-  
Avg Dividend yield %0.73.4 20.2%  
Book value per share (Unadj.) Rs626.12,119.5-  
Shares outstanding (eoy) m45.75848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x9.01.6 555.7%   
Avg P/E ratio x38.626.1 148.0%  
P/CF ratio (eoy) x32.511.4 285.8%  
Price / Book Value ratio x8.21.5 562.7%  
Dividend payout %26.187.5 29.9%   
Avg Mkt Cap Rs m236,2252,634,185 9.0%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m4,0370-   
Avg. sales/employee Rs Th035,999.8-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,248.9-  
INCOME DATA
Net Sales Rs m26,1101,618,010 1.6%  
Other income Rs m6270-   
Total revenues Rs m26,7361,618,010 1.7%   
Gross profit Rs m8,359443,093 1.9%  
Depreciation Rs m1,150130,785 0.9%   
Interest Rs m10731,780 0.3%   
Profit before tax Rs m7,729280,527 2.8%   
Minority Interest Rs m01,274 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-184,151 0.0%   
Tax Rs m1,603-3,425 -46.8%   
Profit after tax Rs m6,126101,076 6.1%  
Gross profit margin %32.027.4 116.9%  
Effective tax rate %20.7-1.2 -1,699.1%   
Net profit margin %23.56.2 375.6%  
BALANCE SHEET DATA
Current assets Rs m23,9651,092,798 2.2%   
Current liabilities Rs m8,529953,012 0.9%   
Net working cap to sales %59.18.6 684.3%  
Current ratio x2.81.1 245.0%  
Inventory Days Days8691 94.7%  
Debtors Days Days296 1.8%  
Net fixed assets Rs m14,571528,478 2.8%   
Share capital Rs m4583,983 11.5%   
"Free" reserves Rs m28,1870-   
Net worth Rs m28,6441,797,302 1.6%   
Long term debt Rs m0827,325 0.0%   
Total assets Rs m38,5353,697,672 1.0%  
Interest coverage x73.29.8 745.2%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.70.4 154.8%   
Return on assets %16.23.6 450.1%  
Return on equity %21.45.6 380.3%  
Return on capital %27.44.9 554.7%  
Exports to sales %3.00-   
Imports to sales %2.50-   
Net fx Rs m1300-   
CASH FLOW
From Operations Rs m6,671257,827 2.6%  
From Investments Rs m-5,750-91,359 6.3%  
From Financial Activity Rs m-1,805-309,281 0.6%  
Net Cashflow Rs m-885-142,812 0.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 79.65 Rs / USD

Compare PFIZER With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare PFIZER With: RPG LIFE SCIENCES  LYKA LABS  GSK PHARMA  NUTRAPLUS PR  SUN PHARMA  



Today's Market

Sensex Zooms 130 Points, Nifty Ends Above 17,600; Financial and IT Stocks Rally(Closing)

Indian benchmark indices ended on a positive note amid a highly volatile session. This was on the back of metal stocks along with banking and financials.